Abstract
In the early stages of COVID-19 clinical illness, the ability to oxygenate is impaired However, the patient does not necessarily display the conventionally expected signs or symptoms of respiratory failure, including shortness of breath Given the above, HCP's must remain vigilant and proactively look for 'red flags' described herein, such as the appearance of =3%-5% drop in SpO2 after approximately 60 s of mild activity/ambulation, SpO2/FiO2 ratio <300, SpO2 <93% on room air, and the presence of hypoxemia without tachypnea [Figure 1] [4,11,12] In summary, this expert group views AH as the proverbial "canary in the coalmine" and the first harbinger of future respiratory deterioration in COVID-19 patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
